RQM+ offers end-to-end biological evaluation services through Jordi Labs, an RQM+ company. With deep expertise in regulatory requirements and biocompatibility testing, we guide clients through the complex process of ensuring medical device safety and regulatory compliance. By leveraging advanced methodologies and ISO 10993 standards, RQM+ provides biological evaluations that align with both FDA and international regulations, enabling you to bring safe and compliant products to market.
RQM+ follows a structured, ISO 10993-based approach to biological evaluations, encompassing every stage from initial risk assessment to detailed regulatory submissions. Our evaluation process includes:
Biological safety assessment is critical for ensuring that materials are biocompatible and do not pose health risks. RQM+ provides a full suite of biological endpoint tests, including the foundational “Big Three” assessments—cytotoxicity, skin sensitization, and irritation testing—as well as a range of additional evaluations, such as:
Our approach integrates in vitro, in vivo, and chemical characterization methods to cover a wide array of biological risks, ensuring thorough evaluation tailored to your product’s specific needs.
Ensuring regulatory compliance is at the heart of what we do. RQM+ has a deep understanding of both FDA guidelines and ISO 10993 standards, making us a trusted partner for global regulatory submissions.
Our team develops comprehensive BEPs aligned with ISO 10993-1, outlining the necessary biological testing and justifying any endpoints that do not require testing.
We conduct thorough chemical analyses to identify potential risks from device materials, supported by our toxicology experts who perform detailed risk assessments based on current scientific guidelines.
At Jordi Labs, an RQM+ company, we excel at developing custom protocols for unique materials and products. With over 40 years of experience in chemical testing and characterization, our PhD-level scientists design testing strategies that maximize efficiency and avoid unnecessary tests. This tailored approach is especially valuable for medical devices and pharmaceutical packaging that incorporate innovative materials.
We support every stage of product development, from initial R&D through pre-clinical validation and final documentation, ensuring a seamless path to regulatory compliance.
RQM+ offers a comprehensive evaluation approach, integrating biological evaluations with chemical characterization, toxicological risk assessments, and extractables and leachables (E&L) testing. This holistic service ensures that every aspect of chemical and biological safety is addressed, providing your team with a thorough understanding of your product’s safety profile.
By combining these services, RQM+ provides clients with reliable data and actionable insights that streamline the regulatory process and support informed decision-making.
Our expertise at RQM+ is backed by a team of PhD-level toxicologists and analytical chemists who deliver scientific precision and regulatory insight. We provide custom protocols that meet global standards, ensuring that your product is fully evaluated for both safety and compliance. With a focus on efficiency and accuracy, RQM+ offers comprehensive biological evaluations that accelerate time to market without compromising on safety.
Ensure your device meets the highest biocompatibility standards. Talk to our experts today.
GLOBAL BOTTOM CTA INSTRUCTIONS:
To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.
Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!
United States HQ 2790 Mosside Blvd. United States (U.S.) |
Europe HQ 3rd Floor, 1 Ashley Road Altrincham, Cheshire, |
©2024 RQM+ All Rights Reserved | Privacy Policy | Cookies Policy